DEFERASIROX
NDC 59651-447, DEFERASIROX, granule, from Aurobindo Pharma Limited.
- Product NDC
- 59651-447
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215137
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-447 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFERASIROX90 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-447-30 | 59651044730 | 30 PACKET in 1 CARTON (59651-447-30) / 1 GRANULE in 1 PACKET (59651-447-38) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c220484e-1e6a-4a0c-a221-60223f3bc24c
Use it
Look up 59651-447 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-447 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-447. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.